Join Dr. Michael Germain, and Dr. Mark Russo through their “Case reviews using TruGraf for the community Nephrologist” and discover typical “real-world” case examples of how gene expression can enhance clinical information in post-transplant community care.

Learn about the use of gene expression biomarkers for the earliest possible detection of “silent” subclinical acute rejection.

Discover from clinicians how to detect and address “silent” rejection in patients with stable renal function.

Find out how TruGraf, a clinically validated blood test, offers a superior alternative to other modalities (biopsies and dd-cfDNA) for serial surveillance